Work

HOXA9 Is a Novel Therapeutic Target in Multiple Myeloma.

Year: 2009

Type: article

Source: Blood

DOI: 10.1182/blood.v114.22.832.832

Authors: Michael A Chapman, Jean-Philippe Brunet, Jonathan J Keats, Angela Baker, Mazhar Adli, Anna C. Schinzel, Gregory Ahmann, Harview Christina, Anna Moore, Vijayalakshmi Shanmugam, Louise M. Perkins, Daniel Auclair, William C. Hahn, Bradley E. Bernstein, Leif Bergsagel, Rafael Fonseca, John Carpten, Jeffrey Trent, Todd R. Golub

Institutions: Broad Institute, Mayo Clinic in Arizona, Translational Genomics Research Institute, Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute, Multiple Myeloma Research Foundation

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2978430904

FWCI:

Cites:

Cited by: 2

Related to: 10